Previous work has shown that tumor Ag presentation at this time occurs only by cross‐presentation [14], and an artificially‐induced immunogenic tumor cell death immediately after tumor challenge may therefore stimulate host APC that are capable of driving effector CD8+ T cell differentiation. Here, CD8A is linked to neoplasm.